CCO Premium Access

Ejection fraction vs. global longitudinal strain for cancer treatment surveillance

Topic: Cardiovascular Toxicity Monitoring

Congress Presentation

About the speaker

Professor Ana Barac

Inova Health System, Fairfax (United States of America)
10 presentations
1 follower

4 more presentations in this session

Virtual guidelines taskforces

Thumbnail

Role of GLP-1 in cardio-oncology

Speaker: Assistant Professor D. Farmakis (Athens, GR)

Thumbnail

Indications for SGLT2i to prevent cardiovascular toxicity

Speaker: Professor A. Abreu (Lisbon, PT)

Thumbnail

Troponin monitoring during immune checkpoint inhibitors treatment

Speaker: Doctor W. Meijers (Rotterdam, NL)

Thumbnail

Access the full session

Virtual guidelines task force

Speakers: Professor A. Barac, Assistant Professor D. Farmakis, Professor A. Abreu, Doctor W. Meijers
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Related content

null Premium Access

Role of GLP-1 in cardio-oncology

21 June 2025

null Premium Access

Indications for SGLT2i to prevent cardiovascular toxicity

21 June 2025

null Premium Access

Troponin monitoring during immune checkpoint inhibitors treatment

21 June 2025

ESC 365 is supported by